Endoscopic third ventriculostomy has developed into a therapeutic alternative to shunting for the management of carefully selected patients with primarily noncommunicating hydrocephalus. This procedure, however, requires a general anesthetic and necessitates violation of the brain parenchyma and manipulation near vital neural structures to access the floor of the third ventricle. Using two cadavers and off-the-shelf angiographic catheters, we sought to determine whether it was possible to navigate a catheter, angioplasty balloon, and stent percutaneously through the subarachnoid space from the thecal sac into the third ventricle so as to perform a third ventriculostomy from below. METHODS: Using biplane angiography and off-the-shelf angiographic catheters along with angioplasty balloons and stents, we were able to pass a stent coaxially from the thecal sac to and across the floor of the third ventricle so as to achieve a third ventriculostomy from below. RESULTS: Coaxial catheter techniques allowed for the percutaneous insertion of a stent across the floor of the third ventricle. Ventriculostomy was confirmed by injecting contrast medium into the lateral ventricle and seeing it pass through the stent and into the chiasmatic cistern. CONCLUSION: We describe the performance of third ventriculostomies in two cadavers by use of the new concept of percutaneous intradural neuronavigation. This procedure may obviate the need for general anesthetic and minimize the potential for brain and vascular injury, especially if ultimately combined with magnetic resonance fluoroscopy.
A
lthough Walter Dandy first proposed the use of third ventriculostomy in 1922, the management of noncommunicating hydrocephalus by use of endoscopic third ventriculostomy (ETV) was developed by William Mixter (12) in 1923. Interest in ETV, however, decreased after the development of the valved shunt in 1949 (14) . The development of the solid rod lens endoscope and the subsequent flexible, steerable fiberoptic endoscope in the 1960s by Harold Hopkins brought neuroendoscopy and ETV back into favor (15) . In the 1970s, Hopkins began to perform ETV using his rod lens system. ETV is currently being performed primarily for patients with noncommunicating hydrocephalus who also have preservation of communication between the subarachnoid space and the venous system (15) . The procedure is conducted with the patient under general anesthesia. The endoscope with a working channel is inserted using the usual coronal coordinates through the brain, and the lateral ventricle is punctured. The endoscope is then advanced through the foramen of Monro and into the third ventricle. Once the floor of the third ventricle is identified, the mamillary bodies are visualized posteriorly and the in-fundibular and optic recesses are identified anteriorly. Midway between the anterior and posterior landmarks, the floor is punctured and fenestrated.
The primary advantage of ETV is the lack of permanent implantation of a foreign mechanical body that can both malfunction and become infected. Complications secondary to ETV include intraparenchymal hemorrhage; subarachnoid hemorrhage; infection; subdural hematoma; and hypothalamic, midbrain, forniceal, and cranial nerve injury (1-4, 8, 11, 15, 16, 18) . The overall morbidity and mortality of this procedure have been estimated to be 5 to 17% (4, 6) .
In 2001, we began investigating the possibility of performing a variety of neurosurgical procedures by accessing the head via the lumbar subarachnoid space. This approach, called percutaneous intradural neuronavigation (PIN), was made possible by advances in neuroimaging and endovascular devices. This article describes our attempt to perform third ventriculostomy using PIN technology.
MATERIALS AND METHODS
Two human adult cadavers were obtained through the willed body program at the University of Texas Southwestern Medical Center at Dallas. The body was placed face down on the angiography table (Toshiba, Tokyo, Japan). The lumbar spine was visualized, and a Seldinger needle was inserted into the L4-L5 interspace at the midline ( Fig.   1 ). Fluoroscopy was used to ensure proper positioning of the needle into the subarachnoid space. A 0.035-inch hydrophilic wire was then inserted and advanced under fluoroscopic visualization to the thoracic level. A 6-French guiding angiographic sheath (Cook, Inc., Bloomington, IN) was then passed over the wire and placed as a working port into the lumbar subarachnoid space (Fig. 2) . A saline flush was connected to keep the thecal sac inflated. Once access to the thecal sac was achieved, a 6-French, 90-cm angiographic guiding catheter (Fasguide; Boston Scientific/Target, Fremont, CA) was advanced over a wire with the catheter tip placed at the anterior aspect of the spinal cord at C1 (Figs. 3 and 4) . A 0.038-inch microcatheter (Tracker 38; Boston Scientific/Target) over a 0.018-inch steerable Fasguide microwire was then advanced coaxially along the clivus in the midline and into the suprasellar cistern (Fig. 5) . Contrast medium was injected through the catheter, and the cistern margins were visualized. At this point, a coronal ventriculostomy was inserted, and the lateral ventricles and third ventricle were opacified with contrast medium (Fig. 6) . The guide catheter was advanced over a wire to the base of the third ventricle (Fig. 7) . The wire and catheter were then advanced across the floor of the third ventricle, and the microcatheter was placed into the third ventricle (Fig. 8) . A 300-mm, 0.014-inch microwire (PT Graphix; Boston Scientific/Scimed, Maple Grove, MN) was then placed through the catheter and into the ventricle. The microcatheter was removed, and a 19 ϫ 3.3-mm angioplasty balloon with loaded stent (Maverick; Boston Scientific/Scimed) was placed straddling the ventricle floor (Fig. 9) . Once inflated, it was deflated and removed, leaving the stent across the fenestra- 
FIGURE 7. Fluoroscopic image showing the guide catheter indenting the anterior floor of the third ventricle (arrow).
tion (Fig. 10) . Contrast medium was reinjected through the coronal ventriculostomy, confirming patency and communication between the third ventricle and the suprasellar cistern (Fig. 11) . All devices were removed except the stent.
DISCUSSION
In carefully chosen patients, ETV is an effective alternative to shunting for the management of noncommunicating hydrocephalus. A number of articles report long-term success rates of 33 to 95% (4-7, 9, 10, 13, 17) . Relative shortcomings of this procedure include the need for a general anesthetic, the need to traverse the frontal lobe, and the risk of injury to major arteries and neural structures.
PIN-directed third ventriculostomy could ideally be performed under awake sedation and does not require penetration of the neural parenchyma except at the base of the third ventricle. The procedure outlined above was performed in two cadavers by use of fluoroscopic guidance and instruments designed for endovascular surgery. These relatively atraumatic devices are routinely moved through arteries and veins without incident. Their mechanical characteristics should produce a very low incidence of neural and vascular injury as they are manipulated through the subarachnoid space.
A significant shortcoming of the above-described procedure is the need for contrast injection into the ventricles through a ventriculostomy to visualize the third ventricle floor before puncture, fenestration, and stenting. Preliminary work in our laboratory indicates that the PIN third ventriculostomy will ultimately be performed using real-time, continuous magnetic resonance fluoroscopy or catheterand-wire-based magnetic resonance imaging, possibly combined with fiberoptic endoscopy. These forms of imaging will obviate the need for contrast filling of the cisterns or ventricles while at the same time providing clear visualization of the brain parenchyma, ventricles, catheter, and vasculature during device manipulation and placement.
CONCLUSION
PIN is a novel approach to treatment of intracranial and intraspinal disease. The performance of third ventriculostomies in two cadavers using off-the-shelf devices designed for endovascular procedures points to the promising nature of this surgical technique. Issues that remain to be resolved include the risk of vascular injury when traversing the subarachnoid space and puncturing the attenuated third ventricle floor and the risk of potential injury to the hypothalamus and thalamus during device navigation and insertion. Advances in magnetic resonance fluoroscopy and instrument design not only should make this particular procedure safer and more effective but also may open new avenues for neurological surgery without having to directly enter the cranial vault.
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